ARTG Entry

BORTRACZO

ARTG entry for BORTRACZO (bortezomib), ARTG 444811 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Glenmark Pharmaceuticals
• Active ingredient: bortezomib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 444811